NDC 55513-998 – Evenity
Romosozumab 105 mg/1.17mL · Injection, Solution · Subcutaneous
Product NDC55513-998
Product details
- Brand name
- Evenity
- Generic name
- Romosozumab-aqqg
- Labeler
- Amgen, Inc
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761062
- Marketed since
- July 1, 2024
- Listing expires
- December 31, 2027
Active ingredients
- Romosozumab 105 mg/1.17mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 55513-998-02 | 2 SYRINGE, GLASS in 1 CARTON (55513-998-02) / 1.17 mL in 1 SYRINGE, GLASS (55513-998-01) | Jul 1, 2024 |
Recalls mentioning this NDC
- D-0539-2025 Jul 30, 2025 · Class II
CGMP Deviations; potential temperature excursions due to transit delays